SCMU
BSX icon

Steadfast Capital Management (UK)’s Boston Scientific BSX Stock Holding History

Steadfast Capital Management (UK)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-28,008
Closed -$1.24M – 5
2022
Q1 		$1.24M Buy
+28,008
New +$1.21M 1.73% 20

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Steadfast Capital Management (UK)'s BSX Position: Q2 2022 in Review

Steadfast Capital Management (UK) sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 28,008 shares — an estimated $1.24M sold.

Steadfast Capital Management (UK) first reported a position in BSX in Q1 2022 and held it in 1 quarter. The position peaked at $1.24M in Q1 2022. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Steadfast Capital Management (UK) reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
  • Steadfast Capital Management (UK) sold 28,008 Boston Scientific shares in Q2 2022, an estimated $1.24M.
  • Steadfast Capital Management (UK) first reported a position in Boston Scientific in Q1 2022 and held it in 1 quarter.
  • Steadfast Capital Management (UK)'s Boston Scientific position peaked at $1.24M in Q1 2022.
  • 878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Steadfast Capital Management (UK)'s 13F filing for Q2 2022.